Steven O'Day - Nov 14, 2024 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chief Medical Officer
Signature
/s/Christine Klaskin, as attorney-in-fact for Steven O'Day
Stock symbol
AGEN
Transactions as of
Nov 14, 2024
Transactions value $
$0
Form type
4
Date filed
11/18/2024, 04:05 PM
Previous filing
Jun 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +50K $0.00 50K Nov 14, 2024 Common Stock 50K $2.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time retention award comprised of options to purchase common stock, which were granted to certain key employees, including our executive officers. These options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan and will vest on November 15, 2025.